Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral nanocurcumin for ankylosing spondylitis
IRCT2017052927520N7Phase 3Completed
- Sponsor
- Connective Tissue Diseases Research Center
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of curcumin in ankylosing spondylitis (AS), sponsored by Connective Tissue Diseases Research Center. Started Apr 2017; status: completed.
02
Drugs
curcumin
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on IRCT2017052927520N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017052927520N7.